Supportive care in multiple myeloma

Asher A Chanan Khan, Kena C. Miller

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Significant progress in the treatment of multiple myeloma has resulted in improvement of disease control with a trend toward overall and progression-free survival benefit. With the availability of several new therapeutic agents and combinations, a careful emphasis should be placed in the management of disease- and therapy-associated complications. Aggressive management of these complications can impact patients' quality of life as well as treatment outcome. This review highlights some of the critical supportive care measures integral to the optimal care of patients with multiple myeloma.

Original languageEnglish (US)
Pages (from-to)42-50
Number of pages9
JournalClinical Lymphoma and Myeloma
Volume7
Issue number1
StatePublished - Jul 2006
Externally publishedYes

Fingerprint

Multiple Myeloma
Critical Care
Disease Management
Disease-Free Survival
Patient Care
Therapeutics
Quality of Life

Keywords

  • Anemia
  • Osteonecrosis of the jaw
  • Skeletal complications
  • Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Hematology

Cite this

Supportive care in multiple myeloma. / Chanan Khan, Asher A; Miller, Kena C.

In: Clinical Lymphoma and Myeloma, Vol. 7, No. 1, 07.2006, p. 42-50.

Research output: Contribution to journalArticle

Chanan Khan, Asher A ; Miller, Kena C. / Supportive care in multiple myeloma. In: Clinical Lymphoma and Myeloma. 2006 ; Vol. 7, No. 1. pp. 42-50.
@article{5fced8539afc409f89e0fc25b226b82f,
title = "Supportive care in multiple myeloma",
abstract = "Significant progress in the treatment of multiple myeloma has resulted in improvement of disease control with a trend toward overall and progression-free survival benefit. With the availability of several new therapeutic agents and combinations, a careful emphasis should be placed in the management of disease- and therapy-associated complications. Aggressive management of these complications can impact patients' quality of life as well as treatment outcome. This review highlights some of the critical supportive care measures integral to the optimal care of patients with multiple myeloma.",
keywords = "Anemia, Osteonecrosis of the jaw, Skeletal complications, Therapy",
author = "{Chanan Khan}, {Asher A} and Miller, {Kena C.}",
year = "2006",
month = "7",
language = "English (US)",
volume = "7",
pages = "42--50",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2669",
publisher = "Cancer Media Group",
number = "1",

}

TY - JOUR

T1 - Supportive care in multiple myeloma

AU - Chanan Khan, Asher A

AU - Miller, Kena C.

PY - 2006/7

Y1 - 2006/7

N2 - Significant progress in the treatment of multiple myeloma has resulted in improvement of disease control with a trend toward overall and progression-free survival benefit. With the availability of several new therapeutic agents and combinations, a careful emphasis should be placed in the management of disease- and therapy-associated complications. Aggressive management of these complications can impact patients' quality of life as well as treatment outcome. This review highlights some of the critical supportive care measures integral to the optimal care of patients with multiple myeloma.

AB - Significant progress in the treatment of multiple myeloma has resulted in improvement of disease control with a trend toward overall and progression-free survival benefit. With the availability of several new therapeutic agents and combinations, a careful emphasis should be placed in the management of disease- and therapy-associated complications. Aggressive management of these complications can impact patients' quality of life as well as treatment outcome. This review highlights some of the critical supportive care measures integral to the optimal care of patients with multiple myeloma.

KW - Anemia

KW - Osteonecrosis of the jaw

KW - Skeletal complications

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=33748305970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748305970&partnerID=8YFLogxK

M3 - Article

C2 - 16879769

AN - SCOPUS:33748305970

VL - 7

SP - 42

EP - 50

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

SN - 2152-2669

IS - 1

ER -